Log in
Enquire now
‌

US Patent 10416162 Her2 diagnostic methods

Patent 10416162 was granted and assigned to Monogram Biosciences on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
‌
Monogram Biosciences
0
Date Filed
December 19, 2008
0
Date of Patent
September 17, 2019
0
Patent Application Number
12340436
0
Patent Citations Received
‌
US Patent 11780925 ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
‌
US Patent 11939394 Binding molecules that inhibit cancer growth
0
‌
US Patent 11773170 Antibodies that bind EGFR and cMET
Patent Inventor Names
Colombe Chappey
0
Jeff Sperinde
0
John William Winslow
0
Michael Bates
0
Weidong Huang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10416162
0
Patent Primary Examiner
‌
Laura B Goddard
0

Find more entities like US Patent 10416162 Her2 diagnostic methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.